BackBeroni Group Limited Overview

Beroni Group Limited EBIT

Beroni Group Limited's EBIT is $-16M, below the Healthcare sector average of $99B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$6.75M
↑ 19.94% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$16.42M
↓ 24.43% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Beroni Group Limited (BNIGF) FAQ

The latest EBIT for BNIGF is $-16M as of June 2026. That compares with $-13M in the prior-year period — down 24.4% year over year. That is below the Healthcare sector average of $99B. Investors often review this figure alongside Beroni Group Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BNIGF's EBIT moved from $-13M to $-16M — a 24.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Beroni Group Limited's operating scale or balance-sheet position.

Against Healthcare companies, BNIGF currently prints $-16M for EBIT, while the sector average sits near $99B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Beroni Group Limited's growth, margins, and balance sheet.

A EBIT figure of $-16M for BNIGF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $99B. Explore the charts below for those layers of context.

After noting BNIGF's EBIT ($-16M), review year-over-year change from $-13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.